eISSN: 2084-9834
ISSN: 0034-6233
Reumatologia/Rheumatology Supplements
Bieżący suplement Archiwum Reumatologia
Panel Redakcyjny
Zgłaszanie i recenzowanie prac online
Portal dla reumatologów!
Poleć ten artykuł:
streszczenie artykułu:

Update on COVID-19 vaccines and autoimmune-mediated rheumatic diseases

Lakshmanan Suresh

  1. Department of Oral Diagnostic Sciences, University at Buffalo, NY, United States
Data publikacji online: 2021/09/08
Pełna treść artykułu Pobierz cytowanie

Providing lasting long-term immunity through effective vaccines for current and emerging strains of coronavirus disease 2019 (COVID-19) providing lasting long-term immunity is fundamental to overcoming the pandemic. Recently approved COVID-19 vaccines have brought tremendous promise to help end this pandemic. As of July 20, 2021, the main vaccines that have been approved for use in North America and Europe are the mRNA vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna), and the viral vector vaccines ChAdOx1 (AstraZeneca) and Ad26.COV2.S (Johnson & Johnson) [1].
© 2024 Termedia Sp. z o.o.
Developed by Bentus.